November 13, 2007- There is significant underutilization of many guideline-indicated life-saving medical and device therapies for heart failure (HF) patients, according to the Registry to Improve the Use of Evidence-Based Heart Failure Therapies in the Outpatient Setting (IMPROVE HF) study.
November 13, 2007 - Stereotaxis Inc. announced the first atrial fibrillation procedures performed with its partnered ...
November 8, 2007 – Cordis Europe has signed a deal with Volcano Europe, a developer and manufacturer of intravascular ...
Cardiac PET/CT represents a major advancement in cardiovascular diagnostics, offering significant clinical and ...
November 13, 2007 - Bayer HealthCare Pharmaceuticals Inc., a leader in diagnostic imaging, has been awarded a three-year ...
Siemens Medical Solutions has launched its new pocket ultrasound system, the ACUSON P10, which is a little larger than a ...
November 13, 2007 – ImaRx Therapeutics Inc. and Philips will collaborate to evaluate Philips ultrasound technology as ...
SPONSORED CONTENT — Studycast is a comprehensive imaging workflow system that allows healthcare professionals to work ...
November 13, 2007 – A study by an international team of cardiac imaging specialists, led by researchers at Johns Hopkins ...
November 13, 2007 — Arterial Remodeling Technologies (ART) will receive $7.8 million from investors to pursue CE Mark ...
AGA Medical Corp. announced today that it has received FDA and European CE Mark approvals for the AMPLATZER Vascular Plug II ("vascular plug II"), a self- expandable nitinol mesh occlusion device designed to be introduced in a minimally invasive fashion through a catheter.
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
Mortara Instrument’s X-Scribe cardiac stress system reportedly assists in streamlining workflow through its ergonomic features and flexible operation.
Siemens Medical Solutions has launched its new pocket ultrasound system, the ACUSON P10, which is a little larger than a ...
LUMEDX’s Cardiac Transplant solution is an integrated part of the company’s comprehensive suite of cardiovascular ...
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
The MyLab 70XVG from Esaote reportedly leverages the latest electronic components and architectural solutions to deliver ...
November 12, 2007 - American hospitals are making measurable strides in the quality of care provided for patients with ...
St. Jude Medical Inc. announced FDA approval of its first radiofrequency (RF) wireless devices to treat patients with heart failure and with potentially lethal heart arrhythmias.
November 12, 2007
